Suppr超能文献

印度北部地区新冠肺炎患者眼部表现的发病率及其与疾病严重程度的关联。

Incidence and association of ocular manifestations with the disease severity in COVID-19 patients of northern region of India.

作者信息

Kumar Aalok, Anuranjani Lavanya

机构信息

Department of Ophthalmology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.

Department of Obstetrics and Gynaecology, Hind Institute of Medical Sciences, Barabanki, Uttar Pradesh, India.

出版信息

Taiwan J Ophthalmol. 2022 May 19;12(3):312-316. doi: 10.4103/tjo.tjo_12_22. eCollection 2022 Jul-Sep.

Abstract

PURPOSE

Our study aims to find the incidence of ocular manifestations and to investigate the relation of ocular manifestations with the disease severity among coronavirus disease 2019 (COVID-19) patients.

MATERIAL AND METHODS

Our study is a cross-sectional study done between May 15, 2020, and April 15, 2021, at Hind Institute of Medical Sciences, Lucknow, India. All COVID-19 patients who got admitted to our center between May 15, 2020, and April 15, 2021, were included in our study. We included 261 patients in our study. Diagnosis of COVID-19 was made by testing the nasal and pharyngeal swabs by (reverse transcriptase-polymerase chain reaction [RT-PCR]). An RT-PCR test positive was the criteria for admission in the COVID ward. Statistical analyses were performed using the Mann-Whitney -test, Chi-square test, and Kolmogorov-Smirnov test. < 0.01 was considered statistically significant.

RESULTS

We included 261 patients in our study. Out of 261 patients, ocular manifestations were found in 43 (16.4%) patients. The patients with ocular manifestations had higher neutrophil counts, erythrocyte sedimentation rate (ESR), procalcitonin (PCT), C-reactive protein (CRP), and D-dimer values ( < 0.001). Patients with ocular manifestations were relatively more symptomatic concerning fever and myalgia.

CONCLUSION

The incidence of ocular manifestations in COVID-19 patients was 16.4%. Ocular manifestation was significantly associated with raised neutrophil counts, CRP, ESR, PCT, and D-dimer values. Ocular manifestation was also significantly associated with higher body temperature and higher mean age. The findings of the study are suggestive of more severe disease in patients of COVID-19 with ocular manifestations.

摘要

目的

我们的研究旨在找出2019冠状病毒病(COVID-19)患者眼部表现的发生率,并调查眼部表现与疾病严重程度之间的关系。

材料与方法

我们的研究是一项横断面研究,于2020年5月15日至2021年4月15日在印度勒克瑙的印度医学科学研究所进行。2020年5月15日至2021年4月15日期间入住我们中心的所有COVID-19患者均纳入我们的研究。我们的研究纳入了261名患者。通过(逆转录聚合酶链反应[RT-PCR])检测鼻拭子和咽拭子来诊断COVID-19。RT-PCR检测呈阳性是进入COVID病房的标准。使用曼-惠特尼检验、卡方检验和柯尔莫哥洛夫-斯米尔诺夫检验进行统计分析。P < 0.01被认为具有统计学意义。

结果

我们的研究纳入了261名患者。在261名患者中,43名(16.4%)患者出现了眼部表现。出现眼部表现的患者中性粒细胞计数、红细胞沉降率(ESR)、降钙素原(PCT)、C反应蛋白(CRP)和D-二聚体值更高(P < 0.001)。出现眼部表现的患者在发热和肌痛方面症状相对更明显。

结论

COVID-19患者眼部表现的发生率为16.4%。眼部表现与中性粒细胞计数、CRP、ESR、PCT和D-二聚体值升高显著相关。眼部表现还与更高的体温和更高的平均年龄显著相关。该研究结果表明,有眼部表现的COVID-19患者病情更严重。

相似文献

1
Incidence and association of ocular manifestations with the disease severity in COVID-19 patients of northern region of India.
Taiwan J Ophthalmol. 2022 May 19;12(3):312-316. doi: 10.4103/tjo.tjo_12_22. eCollection 2022 Jul-Sep.
2
Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China.
JAMA Ophthalmol. 2020 May 1;138(5):575-578. doi: 10.1001/jamaophthalmol.2020.1291.
3
Ocular manifestations of coronavirus disease 2019.
Graefes Arch Clin Exp Ophthalmol. 2020 Sep;258(9):1959-1963. doi: 10.1007/s00417-020-04777-7. Epub 2020 Jun 6.
5
Ocular Manifestations of Hospitalized Patients with COVID-19 in Northeast of Iran.
Ocul Immunol Inflamm. 2020 Jul 3;28(5):739-744. doi: 10.1080/09273948.2020.1773868. Epub 2020 Jun 22.
6
Infectious rate of ocular discharges in patients with approved COVID-19 respiratory infection.
J Family Med Prim Care. 2022 May;11(5):1781-1784. doi: 10.4103/jfmpc.jfmpc_689_21. Epub 2022 May 14.
7
Manifestations and Virus Detection in the Ocular Surface of Adult COVID-19 Patients: A Meta-Analysis.
J Ophthalmol. 2021 Jun 19;2021:9997631. doi: 10.1155/2021/9997631. eCollection 2021.
8

本文引用的文献

2
Clinical characteristics of 82 cases of death from COVID-19.
PLoS One. 2020 Jul 9;15(7):e0235458. doi: 10.1371/journal.pone.0235458. eCollection 2020.
3
Ocular Manifestations of Hospitalized Patients with COVID-19 in Northeast of Iran.
Ocul Immunol Inflamm. 2020 Jul 3;28(5):739-744. doi: 10.1080/09273948.2020.1773868. Epub 2020 Jun 22.
4
The trinity of COVID-19: immunity, inflammation and intervention.
Nat Rev Immunol. 2020 Jun;20(6):363-374. doi: 10.1038/s41577-020-0311-8. Epub 2020 Apr 28.
5
Clinical characteristics of 225 patients with COVID-19 in a tertiary Hospital near Wuhan, China.
J Clin Virol. 2020 Jun;127:104363. doi: 10.1016/j.jcv.2020.104363. Epub 2020 Apr 10.
6
C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early.
J Med Virol. 2020 Jul;92(7):856-862. doi: 10.1002/jmv.25871. Epub 2020 Apr 25.
7
SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes.
Geroscience. 2020 Apr;42(2):505-514. doi: 10.1007/s11357-020-00186-0. Epub 2020 Apr 10.
8
C-reactive protein levels in the early stage of COVID-19.
Med Mal Infect. 2020 Jun;50(4):332-334. doi: 10.1016/j.medmal.2020.03.007. Epub 2020 Mar 31.
9
The epidemiology, diagnosis and treatment of COVID-19.
Int J Antimicrob Agents. 2020 May;55(5):105955. doi: 10.1016/j.ijantimicag.2020.105955. Epub 2020 Mar 28.
10
Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China.
JAMA Ophthalmol. 2020 May 1;138(5):575-578. doi: 10.1001/jamaophthalmol.2020.1291.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验